- Home
- QNRX vs BJDX Comparison
QNRX vs BJDX Comparison
Compare QNRX & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- BJDX
- Stock Information
- Founded
- QNRX 2018
- BJDX 2015
- Country
- QNRX United States
- BJDX United States
- Employees
- QNRX N/A
- BJDX N/A
- Industry
- QNRX Medical/Dental Instruments
- BJDX Medical Specialities
- Sector
- QNRX Health Care
- BJDX Health Care
- Exchange
- QNRX Nasdaq
- BJDX Nasdaq
- Market Cap
- QNRX 4.8M
- BJDX 3.9M
- IPO Year
- QNRX N/A
- BJDX 2021
- Fundamental
- Price
- QNRX $10.08
- BJDX $1.80
- Analyst Decision
- QNRX
- BJDX
- Analyst Count
- QNRX 0
- BJDX 0
- Target Price
- QNRX N/A
- BJDX N/A
- AVG Volume (30 Days)
- QNRX 840.7K
- BJDX 7.8M
- Earning Date
- QNRX 11-06-2025
- BJDX 11-07-2025
- Dividend Yield
- QNRX N/A
- BJDX N/A
- EPS Growth
- QNRX N/A
- BJDX N/A
- EPS
- QNRX N/A
- BJDX N/A
- Revenue
- QNRX N/A
- BJDX N/A
- Revenue This Year
- QNRX N/A
- BJDX N/A
- Revenue Next Year
- QNRX N/A
- BJDX $55.56
- P/E Ratio
- QNRX N/A
- BJDX N/A
- Revenue Growth
- QNRX N/A
- BJDX N/A
- 52 Week Low
- QNRX $5.01
- BJDX $1.26
- 52 Week High
- QNRX $48.30
- BJDX $12.45
- Technical
- Relative Strength Index (RSI)
- QNRX 44.74
- BJDX 39.85
- Support Level
- QNRX $12.55
- BJDX $1.69
- Resistance Level
- QNRX $13.55
- BJDX $2.34
- Average True Range (ATR)
- QNRX 1.86
- BJDX 0.19
- MACD
- QNRX -0.63
- BJDX -0.13
- Stochastic Oscillator
- QNRX 3.20
- BJDX 6.40
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.